GENERAL ASSEMBLY OF NORTH CAROLINA

1985 SESSION

 

 

CHAPTER 439

HOUSE BILL 639

 

AN ACT CONCERNING REGISTRATION TO MANUFACTURE, DISTRIBUTE, OR POSSESS CONTROLLED SUBSTANCES AND TREATMENT FOR DRUG DEPENDENCE.

 

The General Assembly of North Carolina enacts:

 

Section 1.  G.S. 90-92(a)4. is rewritten to read as follows:  "4.  Clorazepate."

Sec. 2.  G.S. 90-101(c)(5) is amended by replacing the period at the end of the subdivision with a semicolon and by adding the word "and" after the semicolon and is further amended by adding a new subdivision after subdivision (5) to read:

"(6)      A practitioner, as defined in G.S. 90-87(22)a., who is required to be licensed in North Carolina by his respective licensing board."

Sec. 3.  G.S. 90-102(c) is amended by deleting the second and third sentences of the subsection.

Sec. 4.  G.S. 90-102(d) is rewritten to read as follows:

"(d)      Manufacturers and distributors registered or licensed under federal law to manufacture or distribute controlled substances included in Schedules I through VI of this Article are entitled to registration under this Article, but this registration is expressly made subject to the provisions of G.S. 90-103."

Sec. 5.  G.S. 90-109.1(b) is rewritten to read as follows:

"(b)      An individual who requests treatment or rehabilitation for drug dependence in a program where medical services are to be an integral component of his treatment shall be examined and evaluated by a practitioner before receiving treatment and rehabilitation services. If a practitioner performs an initial examination and evaluation, the practitioner shall prescribe a proper course of treatment and medication, if needed. That practitioner may authorize another practitioner to provide the prescribed treatment and rehabilitation services."

Sec. 6.  This act shall become effective October 1, 1985.

In the General Assembly read three times and ratified, this the 21st day of June, 1985.